We are extremely excited that the CRASH-3 trial is now in the final phase – with just 7 months left until we reach our 13,000 patient sample size. To date 171 hospitals in 28 countries have enrolled patients – an incredible global collaboration of doctors, nurses, intensivists, pharmacists and everyone else involved. We must continue…